154 related articles for article (PubMed ID: 24231708)
1. [Gemcitabine-induced tumor lysis syndrome caused by recurrent breast cancer in a patient without hemodialysis].
Kawaguchi Ushio A; Hattori M; Kohno N; Kaise H; Iwata H
Gan To Kagaku Ryoho; 2013 Nov; 40(11):1529-32. PubMed ID: 24231708
[TBL] [Abstract][Full Text] [Related]
2. Tumor lysis syndrome after treatment with gemcitabine for metastatic transitional cell carcinoma.
Lin CJ; Lim KH; Cheng YC; Chen HH; Wu CJ
Med Oncol; 2007; 24(4):455-7. PubMed ID: 17917099
[TBL] [Abstract][Full Text] [Related]
3. Tumor lysis syndrome following a single dose of capecitabine.
Kurt M; Eren OO; Engin H; Güler N
Ann Pharmacother; 2004 May; 38(5):902. PubMed ID: 15039470
[No Abstract] [Full Text] [Related]
4. Unprecedented case of tumor lysis syndrome in a patient with metastatic pancreatic adenocarcinoma.
Ling W; Sachdeva P; Wong AS; Lee SC; Zee YK
Pancreas; 2012 May; 41(4):659-61. PubMed ID: 22504387
[No Abstract] [Full Text] [Related]
5. Acute tumor lysis syndrome in solid tumors--a case report and review of the literature.
Baeksgaard L; Sørensen JB
Cancer Chemother Pharmacol; 2003 Mar; 51(3):187-92. PubMed ID: 12655435
[TBL] [Abstract][Full Text] [Related]
6. Fatal cholestatic liver failure associated with gemcitabine therapy.
Robinson K; Lambiase L; Li J; Monteiro C; Schiff M
Dig Dis Sci; 2003 Sep; 48(9):1804-8. PubMed ID: 14561005
[TBL] [Abstract][Full Text] [Related]
7. Can CDA deficiency explain tumour lysis syndrome in a child with neuroblastoma receiving gemcitabine?
Moreau E; André N; Coze C; Padovani L; Mercier C; Ciccolini J
Pediatr Blood Cancer; 2010 May; 54(5):781-2. PubMed ID: 20205259
[No Abstract] [Full Text] [Related]
8. Successful Prevention of Tumour Lysis Syndrome in HER2-positive Breast Cancer: Case Report and Literature Review.
Omori S; Shigechi T; Kawaguchi K; Ijichi H; Oki E; Yoshizumi T
Anticancer Res; 2023 May; 43(5):2371-2377. PubMed ID: 37097695
[TBL] [Abstract][Full Text] [Related]
9. Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma.
Nieto-Ríos JF; Zuluaga-Quintero M; Higuita LM; Rincón CI; Galvez-Cárdenas KM; Ocampo-Kohn C; Aristizabal-Alzate A; Florez-Vargas AA; Zuluaga-Valencia GA
J Bras Nefrol; 2016 Jun; 38(2):255-9. PubMed ID: 27438981
[TBL] [Abstract][Full Text] [Related]
10. Tumor lysis syndrome following trastuzumab for breast cancer: a case report and review of the literature.
Taira F; Horimoto Y; Saito M
Breast Cancer; 2015 Nov; 22(6):664-8. PubMed ID: 23420376
[TBL] [Abstract][Full Text] [Related]
11. Setting the record straight: activity of gemcitabine monotherapy for breast cancer.
Reichardt P; Miles D
Oncology; 2004; 66(4):339-40; author reply 341-2. PubMed ID: 15218304
[No Abstract] [Full Text] [Related]
12. [Role of gemcitabine in treatment of metastatic breast cancer].
Latipova DKh; Semiglazova TIu; Filatova LV; Gershanovich ML
Vopr Onkol; 2011; 57(2):139-46. PubMed ID: 21809657
[No Abstract] [Full Text] [Related]
13. Phase II study of gemcitabine as first-line chemotherapy in patients with advanced or metastatic breast cancer.
Possinger K; Kaufmann M; Coleman R; Stuart NS; Helsing M; Ohnmacht U; Arning M
Anticancer Drugs; 1999 Feb; 10(2):155-62. PubMed ID: 10211545
[TBL] [Abstract][Full Text] [Related]
14. Advanced breast cancer: a phase II trial with gemcitabine.
Carmichael J; Possinger K; Phillip P; Beykirch M; Kerr H; Walling J; Harris AL
J Clin Oncol; 1995 Nov; 13(11):2731-6. PubMed ID: 7595731
[TBL] [Abstract][Full Text] [Related]
15. Gemcitabine and vinorelbine combination in patients with metastatic breast cancer.
Sanal SM; Gokmen E; Karabulut B; Sezgin C
Breast J; 2002; 8(3):171-6. PubMed ID: 12047474
[TBL] [Abstract][Full Text] [Related]
16. Prolonged infusion of gemcitabine in stage IV breast cancer: a phase I study.
Akrivakis K; Schmid P; Flath B; Schweigert M; Sezer O; Mergenthaler HG; Possinger K
Anticancer Drugs; 1999 Jul; 10(6):525-31. PubMed ID: 10885899
[TBL] [Abstract][Full Text] [Related]
17. Gemcitabine for palliative treatment in metastatic breast cancer.
Lüftner D; Flath B; Akrivakis C; Grunewald R; Mergenthaler HG; Possinger K
J Cancer Res Clin Oncol; 1998; 124(10):527-31. PubMed ID: 9829855
[TBL] [Abstract][Full Text] [Related]
18. Single-agent gemcitabine is active in previously treated metastatic breast cancer.
Spielmann M; Llombart-Cussac A; Kalla S; Espié M; Namer M; Ferrero JM; Diéras V; Fumoleau P; Cuvier C; Perrocheau G; Ponzio A; Kayitalire L; Pouillart P
Oncology; 2001; 60(4):303-7. PubMed ID: 11408796
[TBL] [Abstract][Full Text] [Related]
19. [ASCO Annual Meeting 2004, New Orleans. Gemcitabine in metastatic breast carcinoma].
Longo F; Mansueto G
Tumori; 2004; 90(5):1-8. PubMed ID: 15656346
[No Abstract] [Full Text] [Related]
20. A review of tumour lysis syndrome with targeted therapies and the role of rasburicase.
Bose P; Qubaiah O
J Clin Pharm Ther; 2011 Jun; 36(3):299-326. PubMed ID: 21501203
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
